Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its fourth-quarter and full-year 2020 results on March 25, 2021, after the market close.
SALT LAKE CITY, March 18, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its fourth-quarter and full-year 2020 results on March 25, 2021, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. EDT to discuss its financial results with analysts and institutional investors. Management on the call will include CEO Dwight Egan, newly appointed CFO Brian Brown, and Reed Benson, General Counsel. The call and webcast will be available via:
If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company’s website. About Co-Diagnostics, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/co-diagnostics-inc-announces-fourth-quarter-and-full-year-2020-earnings-release-date-and-webcast-301249972.html SOURCE Co-Diagnostics | ||||||
Company Codes: NASDAQ-SMALL:CODX |